WebTake a brief break from statin therapy. Sometimes it's hard to tell whether the muscle aches or other problems you're having are statin side effects or just part of the aging process. ... WebMar 29, 2024 · All patients had a history of statin intolerance, defined as the inability to tolerate at least 2 statins, 1 at a low dose, due to a prior adverse event that started or increased during statin therapy and resolved or improved when statin therapy was discontinued. Low‐dose statin therapy was defined as an average daily dose of …
Statins: benefits and risks - GOV.UK
WebMar 4, 2024 · Statin is highly recommended for dyslipidemia to prevent atherosclerosis-related cardiovascular diseases and death. The aim of this study was to compare the … WebFeb 15, 2024 · A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate Safety and Efficacy of Evolocumab (AMG 145) in Addition to Optimal Stable Background Statin Therapy in Chinese Subjects With Primary Hypercholesterolemia and Mixed Dyslipidemia: Actual Study Start Date : May 9, 2024: Actual Primary Completion … shannon leroy nashville tn
Safety and Tolerability of PCSK9 Inhibitors: Current Insights
WebJan 25, 2016 · Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed Dyslipidemia (BERSON) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. WebJul 22, 2024 · Background: Drug combinations rather than increasing doses of one drug can achieve greater efficacy and lower risks. Thus, as an alternative to high-intensity statin … WebMar 25, 2024 · The addition of pemafibrate to statin therapy only led to a significant increase in serum concentrations of creatinine compared with placebo at a dose of 0.2 mg twice a day. ... Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor α modulator, in patients with dyslipidemia: ... shannon leto house